Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
NCT00098280Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Dec 2004
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of eculizumab in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by National Heart, Lung, and Blood Institute. Started Dec 2004; status: completed.
02
Drugs
eculizumab
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT00098280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098280.